BRIGITTA STATOME: Open Payments
NPI 1760759518 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 10 payments from 8 companies in 2025. Trend: 2023 $483 · 2024 $401 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| Pharmacosmos Therapeutics Inc. | 1 | $30 |
| PFIZER INC. | 1 | $25 |
| ACCORD HEALTHCARE, INC. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Celgene Corporation | 1 | $18 |
Products named: PLUVICTO, REBLOZYL, MONOFERRIC, LUTATHERA, IBRANCE, Camcevi, Enhertu, Lenvima.
Industry payments across VA — which companies pay providers there.
